Foreword: Special Topics in Clinical Monitoring (sponsor DoD Hearing Center of Excellence; Pharmaceutical Interventions for Hearing Loss Group)

Int J Audiol. 2018 Sep;57(sup4):S1-S2. doi: 10.1080/14992027.2018.1495816.

Authors

Amy Boudin-George¹, Carmen Brewer², Kelly Watts³

Affiliations

¹ a Department of Defense Hearing Center of Excellence , JBSA Lackland , TX , USA.
² b National Institute on Deafness and other Communication Disorders , Bethesda , MD , USA ;
³ c Ototoxicity Commitee, PIHL Working Group, Core Business Solutions Inc. , Round Rock , TX , USA.

PMID: 30257144
DOI: 10.1080/14992027.2018.1495816

No abstract available

Publication types

Introductory Journal Article

MeSH terms

Adverse Drug Reaction Reporting Systems
Drug Monitoring / methods*
Hearing / drug effects*
Hearing Loss / chemically induced*
Hearing Loss / diagnosis
Hearing Loss / physiopathology
Hearing Loss / prevention & control
Humans
Military Medicine
Risk Assessment
Risk Factors
United States
United States Department of Defense
United States Department of Veterans Affairs
Veterans Health